voice search
Geftinib Tablets - Selective Egfr Tyrosine Kinase Inhibitor, Effective For Advanced Non-small Cell Lung Cancer Treatment
Share

Geftinib Tablets - Selective Egfr Tyrosine Kinase Inhibitor, Effective For Advanced Non-small Cell Lung Cancer Treatment

Price:

Get Latest Price

In Stock

In Stock

Product Overview

Key Features

We are trading and supplying a wide assortment of Geftinib Tablets from Surat, Gujarat, India. Gefitinib is a selective small molecule inhibitor of the epidermal growth factor receptor tyrosine kinase and is an effective treatment for patients with tumours with activating mutations of the EGFR tyrosine kinas domain regardless of line of therapy. This drug used for the treatment of locally advanced or metastatic non-small cell lung cancer, after failure of both platinum-based and taxane-based chemotherapies.

Related Products

More Product From This seller

Company Details

AKI PHARMA, Established in 2015 at Surat in Gujarat, is a leading Exporter,Supplier,Trading Company of Common Medicines & Drugs in India. AKI PHARMA is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading Geftinib Tablets, AKI PHARMA has made a reputed name for itself in the market with high-quality Abiraterone acetate, Accupril Quinapril Tablet, Amlodipine Besylate Tablets, etc.
Focusing on a customer-centric approach, AKI PHARMA has a pan-India presence and caters to a huge consumer base throughout the country. Buy Common Medicines & Drugs in bulk from AKI PHARMA at Trade India quality-assured products.

Business Type

Exporter, Supplier, Trading Company

Employee Count

10

Establishment

2015

Working Days

Monday To Sunday

GST NO

24AWKPT6754E1Z6

Explore Related Categories

Seller Details

GST

GST - 24AWKPT6754E1Z6

4 RatingRating

Surat, Gujarat

Seller Inquiry

Accepts only Foreign inquiries

Ceo

Mr Raj Kapadia

Address

Plot No. 56 V T Nagar Society, Near Sarthana Jakatnaka, Subhash Nagar Road, Surat, Gujarat, 395006, India

Report incorrect details